创新药企上半年业绩频报喜行业步入发展新阶段

动脉网2025-08-09

多家创新药企在2025年上半年交出了亮眼的业绩报告，标志着行业正从依赖国内市场和仿制药模式向以原始创新和全球注册为核心的新阶段转变。甘李药业实现营收20.67亿元，同比增长57.18%，净利润6.04亿元，同比增长101.96%；百济神州首次半年度实现盈利，归母净利润4.50亿元，主要得益于自主研发产品如百悦泽®和安进授权产品的销售增长；乐普生物预计上半年利润不少于2400万元，首次实现盈利，收入...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2558503599?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-09 09:39","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2558503599","market":"hk","top_or_hot":-1,"title":"创新药企上半年业绩频报喜行业步入发展新阶段","media":"动脉网","content":"<div>\n<p>多家创新药企在2025年上半年交出了亮眼的业绩报告，标志着行业正从依赖国内市场和仿制药模式向以原始创新和全球注册为核心的新阶段转变。甘李药业实现营收20.67亿元，同比增长57.18%，净利润6.04亿元，同比增长101.96%；百济神州首次半年度实现盈利，归母净利润4.50亿元，主要得益于自主研发产品如百悦泽®和安进授权产品的销售增长；乐普生物预计上半年利润不少于2400万元，首次实现盈利，收入...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809094416973cf497&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>创新药企上半年业绩频报喜行业步入发展新阶段</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n创新药企上半年业绩频报喜行业步入发展新阶段\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-09 09:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809094416973cf497&s=b><strong>动脉网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>多家创新药企在2025年上半年交出了亮眼的业绩报告，标志着行业正从依赖国内市场和仿制药模式向以原始创新和全球注册为核心的新阶段转变。甘李药业实现营收20.67亿元，同比增长57.18%，净利润6.04亿元，同比增长101.96%；百济神州首次半年度实现盈利，归母净利润4.50亿元，主要得益于自主研发产品如百悦泽®和安进授权产品的销售增长；乐普生物预计上半年利润不少于2400万元，首次实现盈利，收入...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809094416973cf497&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02157","symbol_name":"乐普生物-B","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809094416973cf497&s=b","article_id":"2558503599","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809094416973cf497&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2558503599","pubTimestamp":1754703540,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"多家创新药企在2025年上半年交出了亮眼的业绩报告，标志着行业正从依赖国内市场和仿制药模式向以原始创新和全球注册为核心的新阶段转变。甘李药业实现营收20.67亿元，同比增长57.18%，净利润6.04亿元，同比增长101.96%；百济神州首次半年度实现盈利，归母净利润4.50亿元，主要得益于自主研发产品如百悦泽®和安进授权产品的销售增长；乐普生物预计上半年利润不少于2400万元，首次实现盈利，收入增长主要来自许可合作及普特利单抗注射液的销售收入。此外，国家政策支持也推动了创新药的发展，包括鼓励商业健康保险扩大投资规模等措施。这些积极信号表明，中国创新药行业正在迎来新的发展机遇。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603087":"甘李药业","688235":"百济神州","02157":"乐普生物-B","BK1588":"回港中概股","06978":"永泰生物-B","BK1161":"生物科技","ONC":"百济神州","BK1574":"生物医药B类股","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","06160":"百济神州","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","BK1583":"高瓴概念","BK1500":"做空集合股","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC"},"translate_title":"Innovative pharmaceutical companies frequently report good results in the first half of the year, and the industry has entered a new stage of development","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603087":0.9,"688235":0.9,"ONC":0.9,"06160":0.9,"06978":1,"02157":0.9},"content_text":"多家创新药企在2025年上半年交出了亮眼的业绩报告，标志着行业正从依赖国内市场和仿制药模式向以原始创新和全球注册为核心的新阶段转变。甘李药业实现营收20.67亿元，同比增长57.18%，净利润6.04亿元，同比增长101.96%；百济神州首次半年度实现盈利，归母净利润4.50亿元，主要得益于自主研发产品如百悦泽®和安进授权产品的销售增长；乐普生物预计上半年利润不少于2400万元，首次实现盈利，收入增长主要来自许可合作及普特利单抗注射液的销售收入。此外，国家政策支持也推动了创新药的发展，包括鼓励商业健康保险扩大投资规模等措施。这些积极信号表明，中国创新药行业正在迎来新的发展机遇。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2558503599","isCrawlerRequest":true}